Early effects of streptozotocin-induced diabetes on insulin-like growth factor-I in the kidneys of growth hormone-transgenic and growth hormone- deficient dwarf mice

Experimental Nephrology

Volumn 5, Issue 4, 1997, Pages 337-344

  Jacobs, M L ^a   Chandrashekar, V ^b   Bartke, A ^b   Weber, R F A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Dwarf mice; Growth hormone; Insulin like growth factor I; Kidney growth; Streptozotocin; Transgenic mice

Indexed keywords

BINDING PROTEIN; GLUCOSE; GROWTH HORMONE; SOMATOMEDIN C; STREPTOZOCIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GROWTH HORMONE DEFICIENCY; KIDNEY; KIDNEY MASS; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE;

AGING; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; CATTLE; DIABETES MELLITUS, EXPERIMENTAL; DWARFISM; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; LIVER; MALE; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROMOTER REGIONS (GENETICS); RATS; RECOMBINANT FUSION PROTEINS;

EID: 0030789765     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Lundbaek K, Jensen VA, Olsen TS, Ørskov H, Christensen NJ, Johansen K, Hansen AP, Østerby R: Diabetes, diabetic angiopathy, and growth hormone. Lancet 1970;ii:131-133.
2. Alzaid AA, Dinneen SF, Melton LJ III, Rizza RA: The role of growth hormone in the development of diabetic retinopathy. Diabetes Care 1994;17:531-534.
3. Merimee TJ: Diabetic retinopathy. A synthesis of perspectives. N Engl J Med 1990;322:978-983.
4. Flyvbjerg A: Growth factors and diabetic complications. Diabetic Med 1990;7:387-399.
5. Schaper NC, Verhoeff AJ, Sluiter WJ, Roelse H, Reitsma WD, Doorenbos H: The growth hormone response to growth hormone-releasing hormone and its relationship to serum insulin-like growth factor I in type I diabetes mellitus. Acta Endocrinol 1990;122:13-18.
6. Blankestijn PJ, Derkx FHM, Birkenhäger JC, Lamberts SWJ, Mulder P, Verschoor L, Schalekamp MADH, Weber RFA: Glomerular hyperfiltration in insulin-dependent diabetes mellitus is correlated with enhanced growth hormone secretion. J Clin Endocrinol Metab 1993; 77:498-502.
7. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93.
8. Muntzel M, Hannedouche T, Niesor R, Nöel L-H, Souberbielle J-C, Lacour B, Drüeke T: Long-term effects of a somatostatin analogue on renal haemodynamics and hypertrophy in diabetic rats. Clin Sci 1992;83:575-581.
9. Flyvbjerg A, Thorlacius-Ussing O, Naeraa R, Ingerslev J, Ørskov H: Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomised rats. Diabetologia 1988;31:310-314.
10. Flyvbjerg A, Ørskov H: Kidney tissue insulin-like growth factor 1 and initial renal growth in diabetic rats: Relation to severity of diabetes. Acta Endocrinol 1990;122:374-378.
11. Flyvbjerg A, Frystyk J, Thorlacius-Ussing O, Ørskov H: Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 1989;32: 261-265.
12. Gronbaek H, Nielsen B, Frystyk J, Glyvbjerg A, Ørskov H: Effect of lanreotide on local kidney IGF-I and renal growth in experimental diabetes in the rat. Exp Nephrol 1996;4:295-303.
13. Chen N-Y, Chen WY, Bellush L, Yang C-W, Striker LJ, Striker GE, Kopchick JJ: Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. Endocrinology 1995;136:660-667.
14. Quaife CJ, Mathews LS, Pinkert CA, Hammer RE, Brinster RL, Palmiter RD: Histopathology associated with elevated levels of growth hormone and insulin-like growth factor I in transgenic mice. Endocrinology 1989;124:40-48.
15. Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE: Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulin-like growth factor-I. Am J Pathol 1988;131:398-403.
16. Yang C-W, Striker LJ, Kopchick JJ, Chen WY, Pesce CM, Peten EP, Striker GE: Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene. Kidney Int 1993;43(suppl):90-94.
17. Cheng TC, Beamer WG, Phillips JA, Bartke A, Mallonee RL, Dowling C: Etiology of growth hormone deficiency in Little, Ames, and Snell dwarf mice. Endocrinology 1983;113:1669-1678.
18. Chandrashekar V, Bartke A: induction of endogenous insulin-like growth factor-1 secretion alters the hypothalamic-pituitary-testicular function in growth hormone-deficient adult dwarf mice. Biol Reprod 1993;48:544-551.
19. McGrane MM, de Vente J, Yun J, Bloom J, Park E, Wynshaw A, Wagner T, Rottman EM, Hanson RW: Tissue specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J Biol Chem 1988;263:11443-11451.
20. Steger RW, Bartke A, Parkening TA, Collins T, Cerven R, Yun JS, Wagner TE: Effects of chronic exposure to bovine growth hormone (bGH) on the hypothalamic-pituitary axis in transgenic mice: Relationship to the degree of expression of the PEPCK-bGH hybrid gene. Transgenics 1994;1:245-253.
21. Sotelo AI, Bartke A, Turyn D: Effects of bovine growth hormone (GH) expression in transgenic mice on serum and pituitary immunoreactive mouse GH levels and pituitary GH-releasing factor binding sites. Acta Endocrinol 1993;129: 446-452.
22. Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG: Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990;347:528-533.
23. Wolff GL, Greenman DL, Frigeri LG, Morrissey RL, Suber RL, Felton RP: Diabetogenic response to streptozotocin varies among obese yellow and among lean agouti (BALB/c x VY) F1 hybrid mice. Proc Soc Exp Biol Med 1990; 193:155-163.
24. Rerup C, Tarding F: Streptozotocin- and alloxan-diabetes in mice. Eur J Pharmacol 1969;7: 89-96.
25. Riley WJ, McConnell TJ, Maclaren NK, McLaughlin JV, Taylor G: The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age. Diabetes 1981;30: 718-723.
26. Bowsher RR, Lee W-H, Apathy JM, O'Brien PJ, Ferguson AL, Henry DP: Measurement of insulin-like growth factor-II in physiological fluids and tissues. I. An improved extraction procedure and radioimmunossay form human and rat fluids. Endocrinology 1991;128:805-814.
27. Breier BH, Gallaher BW, Gluckman PD: Radioimmunoassay for insulin-like growth factor-I: Solutions to some potential problems and pitfalls. J Endocrinol 1991;128:347-357.
28. Lee W-H, Bowsher RR, Apathy JM, Smith MC, Henry DP: Measurement of insulin-like growth factor-II in physiological fluids and tissues. II. Extraction and quantification in rat tissues. Endocrinology 1991;128:815-822.
29. Doi T, Striker LJ, Kimata K, Peten EP, Yamada Y, Striker GE: Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. J Exp Med 1991; 173:1287-1290.
30. Catanese VM, Sciavolino PJ, Lango MN: Discordant, organ-specific regulation of insulin-like growth factor-I messenger ribonucleic acid in insulin-deficient diabetes in rats. Endocrinology 1993;132:496-503.
31. Bach LA, Stevenson JL, Allen TJ, Jerums G, Herington AC: Kidney insulin-like growth factor-I mRNA levels are increased in postpubertal diabetic rats. J Endocrinol 1991;129:5-10.
32. Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist HJ, Ørskov H: Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 1990;33:334-338.
33. Pillion DJ, Haskell JF, Meezan E: Distinct receptors for insulin-like growth factor 1 in rat renal glomeruli and tubules. Am J Physiol 1988;255:E504-E512.
34. Flyvbjerg A, Kessler U, Dorka B, Funk B, Ørskov H, Kiess W: Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 1992;35:589-593.
35. Landau D, Chin E, Bondy C, Domene H, Roberts CT, Gronbaek H, Flyvbjerg A, LeRoith D: Expression of insulin-like growth factor binding proteins in the rat kidney: Effects of long-term diabetes. Endocrinology 1995;136: 1835-1842.
36. Bach LA, Cox AJ, Mendelsohn FAO, Herington AC, Werther GA, Jerums G: Focal induction of IGF binding proteins in proximal tubules of diabetic rat kidney. Diabetes 1992;41: 499-507.
37. Murao S, Sato M, Tamaki M, Niimi M, Ishida T, Takahara J: Suppression of episodic growth hormone secretion in streptozotocin-induced diabetic mice: Time-course studies on the hypothalamic pituitary axis. Endocrinology 1995; 136:4498-4504.
38. Fagin JA, Roberts CT Jr., LeRoith D, Brown AT: Coordinate decrease of tissue insulin-like growth factor I posttranscriptional alternative mRNA transcripts in diabetes mellitus. Diabetes 1989;38:428-434.
39. Hammerman MR, Miller SB: The growth hormone insulin-like growth factor axis in kidney revisited. Am J Physiol 1993;265:F1-F14.
40. Tamai H, Kiyohara K, Mukuta T, Kobayashi N, Komaki G, Nakagawa T, Kumagai LF, Aoki TT: Responses of growth hormone and cortisol to intravenous glucose loading test in patients with anorexia nervosa. Metabolism 1991;40: 31-34.
41. Unterman TG, Vazquez RM, Slas AJ, Martyn PA, Phillips LS: Nutrition and somatomedin. XIII. Usefulness of somatomedin-C in nutritional assessment. Am J Med 1985;78:228-234.
42. Salerno F, Locatelli V, Müller EE: Growth hormone hyperresponsiveness to growth hormone-releasing hormone in patients with severe liver cirrhosis. Clin Endocrinol 1987;27:183-190.
43. Mathews LS, Norstedt G, Palmiter RD: Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 1986;83:9343-9347.
44. Werner H, Shen-Orr Z, Stannard B, Burguera B, Roberts CT Jr, LeRoith D: Experimental diabetes increases insulin-like growth factor I and II receptor concentration and gene expression in kidney. Diabetes 1990;39:1490-1497.
45. Bornfeldt KE, Arnqvist HJ, Enberg B, Mathews LS, Norstedt G: Regulation of insulin-like growth factor-I and growth hormone receptor gene expression by diabetes and nutritional state in rat tissues. J Endocrinol 1989;122:651-656.
46. Muchaneta-Kubara EC, Sayed-Ahmed N, Besbas N, Zhang G, Cope GH, El Nahas AM: Experimental diabetic renal growth: Role of growth hormone and insulin-like growth factor-I. Nephrol Dial Transplant 1994;9:1395-1401.
47. Flyvbjerg A, Marshall SM, Frystyk J, Hansen KW, Harris AG, Ørskov H: Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretion. Kidney Int 1992;41:805-812.
48. Marshall SM, Flyvbjerg A, Frystyk J, Korsgaard L, Ørskov H: Renal insulin-like growth factor I and growth hormone receptor binding in experimental diabetes and after unilateral nephrectomy in the rat. Diabetologia 1991;34: 632-639.
49. Liu Z-H, Striker LJ, Phillips C, Chen N-Y, Chen NVY, Kopchick JJ, Striker GE: Growth hormone expression is required for the development of diabetic glomerulosclerosis in mice. Kidney Int 1995;48(suppl 51):37-38.
50. Flyvbjerg A, Frystyk J, Østerby R, Ørskov H: Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats. Am J Physiol 1992;262:E956-E962.
51. Reddi AS, Camerini-Davalos RA: Diabetic nephropathy. An update. Arch Intern Med 1990; 150:31-43.
52. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.